Market Currents
Salix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by...
-
Monday, August 8, 2011, 4:11 PM ETSalix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by $2M. Reaffirms FY11 Revenue guidance of $520M and PAT of $110M (excl. payments to Lupin). Shares +0.5% AH. (PR)
Other date
Latest Earnings Articles
